Regulus Btn


Briefcase Shareholder Briefcase
Email Alerts E-Mail Alerts
Download Center Download Library
RSS News Feeds


(NASDAQ:ISIS) as of 12:03 PM ET on 08/28/02008
Last: 17.90 Change: $0.17 up  (0.95%)
Day High: 17.95 Day Low: 17.65


Recent Releases
08/19/08 Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors
08/13/08 Isis Initiates Clinical Trial of CRP Drug
08/07/08 Isis Reports Financial Results and Highlights for Second Quarter of 2008
 
Analyst Firm Phone
Debjit Chattopadhyay Boenning & Scattergood, Inc.   610-684-5417
Eric Schmidt Cowen and Co., LLC   646-562-1345
Geraldine O'Keeffe Fortis Securities LLC   31-20 527-9150
Adam Walsh Jefferies & Company   617-342-7857
Joseph Schwartz Leerink Swann & Company   617-918-4575
Jim Birchenough Lehman Brothers Inc.   415-274-5393
Alex To Natixis Bleichroeder, Inc.   212-698-3146
Mark Monane Needham & Company   212-705-0346
Edward Tenthoff Piper Jaffray & Co.   212-284-9403
Carol Werther Summer Street Research Partners   617-532-6418
Aaron Reames Wachovia Capital Markets, LLC   617-603-4219

Contact Us
Kristina Lemonidis
Associate Director, Investor Relations

Telephone: 760-603-2331
E-mail: info@isisph.com